@xconomy.com 3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@extremetech.com 4 years ago
FDA Approves CRISPR-Based Coronavirus Test
@xconomy.com 4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com 5 years ago
Imbed Biosciences Gets $2M Boost for Silver-Based Wound Dressings
@techcrunch.com 7 years ago
Move over Cas9, CRISPR-Cas3 might hold the key to solving the antibiotics crisis